Atea Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Atea Pharmaceuticals

08/08/2022 23:02

* Atea Pharmaceuticals Inc  AVIR.OQ  reported a quarterly
adjusted
loss of 38 cents​​ per share for the quarter ended in June. The
mean expectation of four analysts for the quarter was for a loss
of 52 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Atea Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 38 cents​.
    * The mean earnings estimate of analysts had risen by
about 16.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Atea Pharmaceuticals Inc shares had risen by 23.8% this
quarter and lost 1.7% so far this year.
    * The company reported a quarterly loss of $31.34 million.
    * Wall Street's median 12-month price target for Atea
Pharmaceuticals Inc is $7.50 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 8
at 10:02 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.52          -0.38          Beat
 Mar. 31 2022      -0.58          -0.51          Beat
 Dec. 31 2021      0.17           1.34           Beat
 Sep. 30 2021      -0.05          -0.34          Missed